Author:
Garland Suzanne Marie,Williamson Anna-Lise,Brotherton Julia Mary Louise
Reference260 articles.
1. Adebamowo SN, Befano B, Cheung LC, Rodriguez AC, Demarco M, Rydzak G, et al. Different human papillomavirus types share early natural history transitions in immunocompetent women. Int J Cancer. 2022;151(6):920–9.
2. Adler D, Laher F, Wallace M, Grzesik K, Jaspan H, Bekker LG, et al. High rate of multiple concurrent human papillomavirus infections among HIV-uninfected south African adolescents. J Immunol Tech Infect Dis. 2013;2(1):1000106.
3. Ahmed A, Shukla A, Hubbell N, Almujarkesh MK, LaBuda D, Ouchi T. Early identification and intervention in malignant transformation of respiratory papillomatosis. Am J Case Rep. 2023;24:e937665.
4. Ahrlund-Richter A, Cheng L, Hu YOO, Svensson M, Pennhag AAL, Ursu RG, et al. Changes in cervical human papillomavirus (HPV) prevalence at a youth clinic in Stockholm, Sweden, a decade after the introduction of the HPV vaccine. Front Cell Infect Microbiol. 2019;9:59.
5. Akhatova A, Chan CK, Azizan A, Aimagambetova G. The efficacy of therapeutic DNA vaccines expressing the human papillomavirus E6 and E7 Oncoproteins for treatment of cervical cancer: systematic review. Vaccines (Basel). 2021;10(1)